[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].

Autor: Gustafsson I; H:S Frederiksberg Hospital, Kardiologisk-endokrinologisk Klinik E, DK-2000 Frederiksberg. gustafsson@dadlnet.dk, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A
Jazyk: dánština
Zdroj: Ugeskrift for laeger [Ugeskr Laeger] 2006 Feb 06; Vol. 168 (6), pp. 581-4.
Abstrakt: Patients with diabetes have an unfavourable prognosis after an acute myocardial infarction. The DIGAMI 2 study investigated the effect of various metabolic treatment strategies in type 2 diabetic patients with acute myocardial infarction: acutely introduced, long-term insulin treatment did not improve survival when compared with conventional management at similar levels of glucose control. However, good glucose control seems important since the glucose level was found to be a strong predictor of long-term mortality in this patient category.
Databáze: MEDLINE